Recognition and management of fatty acid oxidation defects: A series of 107 patients

Journal of Inherited Metabolic Disease

Volumn 22, Issue 4, 1999, Pages 488-502

  Saudubray, J M ^a   Martin, D ^a   De Lonlay, P ^a   Touati, G ^a   Poggi Travert, F ^a   Bonnet, D ^a   Jouvet, P ^a   Boutron, M ^b   Slama, A ^b   Vianey Saban, C ^c   Bonnefont, J P ^a   Rabier, D ^a   Kamoun, P ^a   Brivet, M ^b  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b BICÊTRE HOSPITAL   (France)

^c HÔPITAL DEBROUSSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLCARNITINE; CARBOXYLIC ACID; CARNITINE; FATTY ACID; TRIACYLGLYCEROL;

BLOOD LEVEL; CATABOLISM; CLINICAL FEATURE; CONFERENCE PAPER; DIET SUPPLEMENTATION; FAST ATOM BOMBARDMENT MASS SPECTROMETRY; FAT INTAKE; FATTY ACID OXIDATION; FEMALE; FIBROBLAST CULTURE; HEART ARRHYTHMIA; HEART DISEASE; HUMAN; INBORN ERROR OF METABOLISM; KIDNEY FAILURE; LIPOLYSIS; LIVER DISEASE; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MYALGIA; MYOGLOBINURIA; NEUROLOGIC DISEASE; PERIPHERAL NEUROPATHY; PROGNOSIS; RETINITIS PIGMENTOSA; SUDDEN DEATH; URINE LEVEL;

DISEASE MANAGEMENT; FATTY ACIDS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LIPID METABOLISM, INBORN ERRORS; MALE; OXIDATION-REDUCTION;

EID: 0033004986     PISSN: 01418955     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (59)

1. Bergman AJ, Donckerwolcke RA, Duran M, et al (1994) Rate-dependent distal renal tubular acidosis and carnitine palmitoyltransferase I deficiency. Pediatr Res 36: 582-588.
2. Bohm N, Uy J, Kiessling M, et al (1982) Multiple acyl-CoA dehydrogenation deficiency (glutaric aciduria type II), congenital polycystic kidneys, and symmetric warty dysplasia of the cerebral cortex in two newborn brothers: II. Morphology and pathogenesis. Eur J Pediatr 139: 60-65.
3. Boles RG, Buck EA, Blitzer MG, et al (1998) Retrospective biochemical screening of fatty acid oxidation disorders in postmortem livers of 418 cases of sudden death in the first year of life. J Pediatr 132: 924-933.
4. Bonnefont JP, Specola NB, Vassault A, et al (1990) The fasting test in paediatrics: application to the diagnosis of pathological hypo- and hyperketotic states. Eur J Pediatr 150: 80-85.
5. Bougnères PF, Saudubray JM, Marsac C, Bernard O, Odièvre M, Girard J (1981) Fasting hypoglycemia resulting from hepatic carnitine palmitoyl transferase deficiency. J Pediatr 98: 742-746.
6. Brivet M, Slama A, Saudubray JM, Legrand A, Lemonnier A (1995) Rapid diagnosis of long chain and medium chain fatty acid oxidation disorders using lymphocytes. Ann Clin Biochem 32: 154-159.
7. Brivet M, Slama A, Millington DS, et al (1996) Retrospective diagnosis of carnitine-acylcarnitine translocase deficiency by acylcarnitine analysis in the proband Guthrie card and enzymatic studies in the parents. J Inher Metab Dis 19: 181-184.
8. Brivet M, Boutron A, Slama A, et al (1999) Defects in activation and transport of fatty acids. J Inher Metab Dis 22: 428-441.
9. Burlina AB, Dionisi-Vici C, Bennett MJ, et al (1994) A new syndrome with ethylmalonic aciduria and normal fatty acid oxidation in fibroblasts. J Pediatr 124: 79-86.
10. Carroll JE, Shumate JB, Brooke MH, Hagberg JM (1981) Riboflavin-responsive lipid myopathy and carnitine deficiency. Neurology 31: 1557-1559.
11. Colevas AD, Edwards JL, Hruban RH, Mitchell GA, Valle D, Hutchins GM (1988) Glutaric acidemia Type II. Arch Pathol Lab Med 112: 1133-1139.
12. Corr PB, Creer MH, Yamada KA, Saffitz JE, Sobel BE (1989) Prophylaxis of early ventricular fibrillation by inhibition of acylcarnitine accumulation. J Clin Invest 83: 927-936.
13. Demaugre F, Bonnefont JP, Colonna M, Cepanec C, Leroux JP, Saudubray JM (1991) Infantile form of carnitine palmitoyltransferase II deficiency with hepatomuscular symptoms and sudden death: physiopathological approach to carnitine palmitoyltransferase II deficiencies. J Clin Invest 87: 859-864.
14. Dimauro S, Dimauro PMM (1973) Muscle carnitine palmitoyl transferase deficiency and myoglobinuria. Science 182: 929-931.
15. Dionisi-Vici C, Burlina AB, Bertini E, et al (1991) Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: clinical and therapeutic considerations. J Pediatr 118: 744-746.
16. Dionisi-Vici C, Garavaglia B, Burlina AB, et al (1996) Hypoparathyroidism in mitochondrial trifunctional protein deficiency. J Pediatr 129: 159-162.
17. Engel AG, Angelini C (1973) Carnitine deficiency of human skeletal muscle associated with lipid storage myopathy : a new syndrome. Science 179: 899-901.
18. Falik-Borenstein ZC, Jordan SC, Saudubray JM, et al (1992) Brief report: renal tubular acidosis in carnitine palmitoyltransferase type 1 deficiency. N Engl J Med 327: 24-27.
19. Fernandes J, Saudubray JM (1995) Diagnostic procedures: function tests and postmortem protocol. In Fernandes J, Saudubray JM, Van den Berghe G, eds. Inborn Metabolic Diseases: Diagnosis and Treatment, 2nd edn. Berlin: Springer-Verlag, 41-46.
20. Freinkel N, Lewis NJ, Azakawa S, Roth SI, German I (1984) The honeybee syndrome: implications of teratogenicity of mannose in rat-embryo culture. N Engl J Med 310: 223-230.
21. Garcia-Silva MT, Ribes A, Campos Y, Garavaglia B, Arenas J (1997) Syndrome of encephalopathy, petechiae, and ethylmalonic aciduria. Pediatr Neurol 17: 165-170.
22. Green A, Marshall TG, Bennett MJ, Gray RGF, Pollit RJ (1985) Riboflavin-responsive ethylmalonyl-adipic aciduria. J Inher Metab Dis 8: 67-70.
23. Greenberg CR, Wanders RJA, Roe CR, Grewar D, Seargeant LE (1997) Complete deficiency of CPT I in an infant born to a mother with acute fatty liver of pregnancy. Poster, 7th International Congress of Inborn Errors of Metabolism, Vienna, May 21-25, 1997. (Abstract).
24. Hale D, Bennett MJ (1992) Fatty acid oxidation disorders: a new class of metabolic diseases. J Pediatr 121: 1-11.
25. Hale DE, Thorpe C, Braat K, et al (1990a) The L-3-hydroxyacyl-CoA dehydrogenase deficiency. In Tanaka K, Coates PM, eds. Fatty Acid Oxidation: Clinical, Biochemical and Molecular aspects. New-York: Alan R. Liss, 503-510.
26. Hale DE, Thorpe C, Braat K, et al (1990b) The L-3-hydroxyacyl-CoA dehydrogenase deficiency. Prog Clin Biol 321: 503-510.
27. Harding CO, Gillingham MB, Van Calcar SC, Wolff JA, Verhoeve JN, Mills MD (1998) Effects of docosahexaenoic acid (DHA) supplementation upon retinal function in children with long chain 3-hydroxyacyl-CoA dehydrogenase deficiency. J Inher Metab Dis 21(supplement 2): O6 (abstract).
28. Harpey JP, Charpentier C, Coude M, Divry P, Paturneau-Jouas M (1987) Sudden infant death syndrome and multiple acyl-coenzyme A dehydrogenase deficiency, ethylmalonic-adipic acidemia, or systemic carnitine deficiency. J Pediatr 110: 881-884.
29. Hug G, Bove KE, Soukup S (1991) Lethal neonatal multiorgan deficiency of carnitine palmitoyltransferase II. N Engl J Med 325: 1862-1864.
30. Innes AM, Seargeant LE, Balachandra K, et al (1997) An expanding spectrum of metabolic disorders can cause acute fatty liver of pregnancy (AFLP), hemolysis, elevated liver enzymes and low platelets syndrome (HELLP), and hyperemesis gravidarum. Am J Hum Genet A252 (abstract).
31. Millington DS, Kodo N, Norwood DL, Roe CR (1990) Tandem mass spectrometry: a new method for acylcarnitine profiling with potential for neonatal screening for inborn errors of metabolism. J Inher Metab Dis 13: 321-324.
32. Millington DS, Terada N, Chace DH, et al (1992) The role of tandem mass spectrometry in the diagnosis of fatty acid oxidation disorders. In Coates PM, Tanaka K, eds. New Developments in Fatty Acid Oxidation. Progress in Clinical and Biological Research. New York: Wiley-Liss, 339-354.
33. Miyajima H, Orii KE, Shindo Y, et al (1997) Mitochondrial trifunctional protein deficiency associated with recurrent myoglobinuria in adolescence. Neurology 49: 833-837.
34. Nada M, Rhead W, Sprecher H, et al (1995) Evidence for intermediate channeling of mitochondrial β-oxidation. J Biol Chem 270: 530-535.
35. Parmi R, Garavaglia B, Saudubray JM, et al (1991) Clinical diagnosis of long-chain acyl-coenzyme A-dehydrogenase deficiency: use of stress and fat-loading tests. J Pediatr 119: 77-80.
36. Pollitt RJ (1989) Disorders of mitochondrial beta-oxidation; prenatal and early post-natal diagnosis and their relevance to Reye's syndrome and sudden infant death. J Inher Metab Dis 12(supplement 1): 215-230.
37. 14 hydroxydicarboxylic aciduria. A new defect in fatty acid oxidation? J Inher Metab Dis 11(supplement 2): 183-185.
38. Rashed MS, Ozand PT, Bennett MJ, Barnard JJ, Govindaraju DR, Rinaldo P (1995) Diagnosis of inborn errors of metabolism in sudden death cases by acylcarnitine analysis of postmortem bile. Clin Chem 41: 1109-1114.
39. Rhead WJ (1990) Screening for inborn errors of fatty acid oxidation in cultured fibroblasts: an overview. In Tanaka K, Coates PM, eds. Fatty Acid Oxidation: Clinical, Biochemical and Molecular aspects. New York: Alan R. Liss, 365-382.
40. 14 dicarboxylic aciduria with favourable evolution. J Inher Metab Dis 9(supplement 2): 297-299.
41. Roettger V, Marshall T, Amendt B, Rhead WJ (1992) Multiple acyl-coenzyme A dehydrogenation disorders (MAD) responsive to riboflavin: biochemical studies in fibroblasts. In Coates PM, Tanaka K, eds. New Developments in Fatty Acid Oxidation. Progress in Clinical and Biological Research. New York: Wiley-Liss, 317-326.
42. Rocchiccioli P, Wanders RJA, Aubourg P, et al (1990) Deficiency of long-chain 3-hydroxyacylCoA dehydrogenase: a cause of lethal myopathy and cardiomyopathy in early childhood. Pediatr Res 28: 657-662.
43. Rumsby G, Seakins JWT, Leonard JV (1986) A simple screening test for medium chain acylCoA dehydrogenase deficiency. Lancet 2: 467.
44. Saudubray JM, Charpentier C (1995) Clinical phenotypes: diagnosis/algorithms. In Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease, 7th edn, New York: McGraw-Hill, 327-400.
45. Saudubray JM, Coudé FX, Demaugre F, Johnson C, Gibson KM, Nyhan WC (1982) Oxidation of fatty acids in cultured fibroblasts : a model system for the detection and study of defects in oxidation. Pediatr Res 16: 877-881.
46. Saudubray JM, Ogier H, Bonnefont JP, et al (1989) Clinical approach to inherited metabolic diseases in the neonatal period: a 20-year survey. J Inher Metab Dis 12(supplement 1): 25-41.
47. Schmidt-Sommerfeld E, Penn D, Duran M, et al (1992) Detection and quantitation of acyl-carnitines in plasma and blood spots from patients with inborn errors of fatty acid oxida-tion. In Coates PM, Tanaka K, eds. New Developments in Fatty Acid Oxidation. Progress in Clinical and Biological Research. New York: Wiley-Liss, 355-362.
48. Smelt AHM, Poorthuis JHM, Onkenhout W, et al (1998) Very long chain acyl-coenzyme A dehydrogenase deficiency with adult onset. Ann Neurol 43: 540-544.
49. Sperl W, Geiger R, Lehnert W, Rhead W (1997) Stridor as the major presenting symptom in riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency. Eur J Pediatr 156: 800-802.
50. Stanley CA, DeLeeuw S, Coates PM, et al (1991) Chronic cardiomyopathy and weakness or acute coma in children with a defect in carnitine uptake. Ann Neurol 30: 709-716.
51. Stanley CA, Sunaryo F, Hale DE, Bonnefont JP, Demaugre F, Saudubray JM (1992) Elevated plasma carnitine in the hepatic form of carnitine palmitoyltransferase-1 deficiency. J Inher Metab Dis 15: 785-789.
52. Tein I, Demaugre F, Bonnefont JP, Saudubray JM (1989) Normal muscle CPT I and CPT II activities in hepatic-presentation patients with CPT I deficiency in fibroblasts. Tissue specific isoforms of CPT I? J Neurol Sci 92: 229-245.
53. Tein I, DeVivo DC, Hale DE, et al (1991) Short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency in muscle: a new cause for recurrent myoglobinuria and encephalopathy. Ann Neurol 30: 415-419.
54. Tyni T, Rapola J, Palotie A, Pihko H (1997) Hypoparathyroidism in a patient with long-chain- 3-hydroxyacyl-coenzyme A dehydrogenase deficiency caused by the G1528C mutation. J Pediatr 131: 766-768.
55. Van Hove JLK, Zhang W, Kahler SG, et al (1993) Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: diagnosis by acylcarnitine analysis in blood. Am J Hum Genet 52: 958-966.
56. Vianey-Saban C, Divry P, Gregersen N, Mathieu M (1987) The inborn errors of mitochondrial fatty acid oxidation. J Inher Metab Dis 10(supplement 1): 159-198.
57. Vianey-Saban C, Divry P, Brivet M, et al (1998) Mitochondrial very-long-chain acyl-coenzyme A dehydrogenase deficiency: clinical characteristics and diagnostic considerations in 30 patients. Clin Chim Acta 269: 43-62.
58. Wilson GN, De Chadarévian JP, Kaplan P, Loehr JP, Frerman FE, Goodman SI (1989) Glutaric aciduria type II: review of the phenotype and report of an unusual glomerulopathy. Am J Med Genet 32: 395-401.
59. Witt DR, Theobald M, Santa-maria M, et al (1991) Carnitine palmitoyl transferase-type 2 deficiency: two new cases and successful prenatal diagnosis. Am J Hum Genet 49(supplement 4): 535 (abstract).